Literature DB >> 12195866

Oxygen homeostasis and cancer: insights from a rare disease.

Patrick H Maxwell1.   

Abstract

Many aspects of physiology and anatomy are precisely adjusted so that the right amount of oxygen reaches cell throughout the body. Hypoxia-inducible factor-1 (HIF-1) is activated by low oxygen tension in all mammalian cells and underpins many aspects of the impressive ability to match oxygen supply and demand. As examples, HIF-1 regulates: local capillary architecture via angiogenic signalling red cell production via erythropoietin cellular metabolism via increased expression of glucose transporters and glycolytic enzymes. HIF-1 is also important in disease, for example in cancer where it is involved in angiogenesis. This review describes how HIF-1 is regulated by oxygen and the central role played by the von Hippel-Lindau tumour suppressor protein. The underlying oxygen sensor is provided by a family of enzymes which oxidize specific proline residues in HIF alpha subunits. Inhibiting these newly discovered enzymes provides a way of activating HIF-1 in the presence of oxygen--an exciting prospect for therapeutic intervention in ischaemic diseases.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12195866      PMCID: PMC4953398          DOI: 10.7861/clinmedicine.2-4-356

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN: 1470-2118            Impact factor:   2.659


  7 in total

Review 1.  Hypoxia--implications for pharmaceutical developments.

Authors:  Lucas Donovan; Scott M Welford; John Haaga; Joseph LaManna; Kingman P Strohl
Journal:  Sleep Breath       Date:  2010-07-14       Impact factor: 2.816

2.  Molecular genetic analysis of FIH-1, FH, and SDHB candidate tumour suppressor genes in renal cell carcinoma.

Authors:  M R Morris; E Maina; N V Morgan; D Gentle; D Astuti; H Moch; T Kishida; M Yao; P Schraml; F M Richards; F Latif; E R Maher
Journal:  J Clin Pathol       Date:  2004-07       Impact factor: 3.411

3.  COX2 is involved in hypoxia-induced TNF-α expression in osteoblast.

Authors:  Yonggang Xing; Renxian Wang; Dafu Chen; Jianping Mao; Rui Shi; Zhihong Wu; Jun Kang; Wei Tian; Chi Zhang
Journal:  Sci Rep       Date:  2015-06-12       Impact factor: 4.379

4.  Erythropoietin in bone homeostasis-Implications for efficacious anemia therapy.

Authors:  Katrina M Lappin; Ken I Mills; Terence R Lappin
Journal:  Stem Cells Transl Med       Date:  2021-01-21       Impact factor: 6.940

5.  HIF-1α inhibits Wnt signaling pathway by activating Sost expression in osteoblasts.

Authors:  Dafu Chen; Yang Li; Zhiyu Zhou; Chengai Wu; Yonggang Xing; Xuenong Zou; Wei Tian; Chi Zhang
Journal:  PLoS One       Date:  2013-06-11       Impact factor: 3.240

6.  Synergistic inhibition of Wnt pathway by HIF-1α and osteoblast-specific transcription factor osterix (Osx) in osteoblasts.

Authors:  Dafu Chen; Yang Li; Zhiyu Zhou; Yonggang Xing; Yu Zhong; Xuenong Zou; Wei Tian; Chi Zhang
Journal:  PLoS One       Date:  2012-12-27       Impact factor: 3.240

7.  A common polymorphism in the oxygen-dependent degradation (ODD) domain of hypoxia inducible factor-1alpha (HIF-1alpha) does not impair Pro-564 hydroxylation.

Authors:  Melanie J Percy; Sharon M Mooney; Mary Frances McMullin; Adrian Flores; Terence R J Lappin; Frank S Lee
Journal:  Mol Cancer       Date:  2003-09-09       Impact factor: 27.401

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.